News
Researchers from Cornell and Northwestern universities have developed a rapid, cell-free method for building nanoparticle ...
A research team with Professor Neha Kamat used synthetic liposomes and bacterial extracts to generate immune responses ...
This study introduces the synthesis of a new class of lipopolymers composed of l-proline monomer units and a phospholipid initiator. By anchoring polyproline chains to the membrane, reversible phase ...
Genprex's oncology program utilizes its systemic, non-viral Oncoprex ® Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form.
Capstan Therapeutics scientists demonstrate that lipid nanoparticles can engineer CAR T cells within the body without laboratory cell manufacturing and ex vivo expansion.
Understanding how synthetic peptidomimetics interact with bacterial membranes is key to developing next-generation antimicrobials. In this study, we investigate the membrane-disruptive behavior of C10 ...
The hope is that their multidisciplinary approach — and the early success of their lipid nanoparticle vaccine — could finally offer a way to stop pancreatic cancer before it takes hold.
Dr. Sumant Ramachandra, Chief Scientific Advisor to CancerVax added, “In the short time I have worked with the research and development team at CancerVax, I have been very impressed with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results